GeneDx Holdings (WGSWW) EBT (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of EBT data on file, last reported at -$62.4 million in Q1 2026.

• EBT for Q1 2026 came in at -$62.4 million, down 926.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$77.5 million (down 101.81% YoY), and the FY2025 annual result was -$21.1 million, up 59.84% from the prior year.
• EBT declined to -$62.4 million in Q1 2026 per WGSWW's latest filing, from -$18.2 million in the prior quarter.
• Over five years, EBT peaked at $10.6 million in Q2 2025 and troughed at -$308.7 million in Q4 2022.
• A 5-year average of -$53.6 million and a median of -$29.4 million in 2024 frame the typical range for EBT.
• The sharpest annual moves came in 2025 and 2026: EBT surged 135.97% in 2025, then plunged 926.29% in 2026.
• A 5-year view of EBT shows it stood at -$308.7 million in 2022, then surged by 91.52% to -$26.2 million in 2023, then surged by 120.68% to $5.4 million in 2024, then plunged by 436.72% to -$18.2 million in 2025, then plunged by 242.4% to -$62.4 million in 2026.
• Business Quant data shows WGSWW's EBT at -$62.4 million in Q1 2026, -$18.2 million in Q4 2025, and -$7.4 million in Q3 2025.